Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Timing rebalancing for tax efficiency involves evaluating thresholds and market conditions. This intro offers actionable timing tips for index funds.
17,111 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Solana posted the largest ETF inflow in months on February 25, signaling renewed institutional interest. Yet on-chain...
A wave of headlines claims cramer says trillion-dollar stocks are the must-watch trend. This article breaks down what...
A hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...
When bitcoin dips under $70k amid a sharp stock sell-off tied to a hawkish FED hold, traders scramble for direction. ...
A steep 2026 selloff has investors weighing Microsoft through a new lens. This guide breaks down the case for microso...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A notable hedge fund adds position in RXO, prompting questions about the stock's future. This guide breaks down what ...
As investors assess concentrix (cnxc) 2026 earnings, this guide breaks down what to watch, how margins may move, and ...
Oil markets face a persistent pricing regime, per Shell’s warning. This guide translates that view into practical inv...
Global equities tumble as Federal Reserve signals higher rates for longer, triggering a broad selloff across risk ass...
A landmark ruling reshapes how investors view the Fed's independence and policy credibility. This could translate int...